Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mike Ingham
Treatment Patterns, Glycemic Control & Bodyweight With Canagliflozin 300 Mg Versus GLP1RAs in Type II Diabetes Patients
Journal of Comparative Effectiveness Research
Health Policy
Related publications
Clinical Implications of Canagliflozin Treatment in Patients With Type 2 Diabetes
Clinical Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
PCV10 Anti-Glycemic Medication Treatment Patterns Among Type II Diabetes Mellitus Patients Initiating Lipid-Altering Regimens
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Canagliflozin for Japanese Patients With Chronic Heart Failure and Type II Diabetes
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Glycemic Control in Type 2 Diabetes Mellitus Patients
Chattagram Maa-O-Shishu Hospital Medical College Journal
Obesity and Poor Glycemic Control in Patients With Type 2 Diabetes
International Journal of Research in Medical Sciences
Depression and Glycemic Control in a Sample of Patients With Type 2 Diabetes
MOJ Addiction Medicine & Therapy
Glycemic Control Is Associated With Atrial Structural Remodeling in Patients With Type 2 Diabetes
BMC Cardiovascular Disorders
Cardiovascular Medicine
Cardiology
Racial Differences in Diabetes-Related Psychosocial Factors and Glycemic Control in Patients With Type 2 Diabetes
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Symptoms and Well-Being in Relation to Glycemic Control in Type II Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes